These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15380232)

  • 1. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
    Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.
    Zhao H; Xin Z; Patel JR; Nelson LT; Liu B; Szczepankiewicz BG; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1825-8. PubMed ID: 15780615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unacylated ghrelin is not a functional antagonist but a full agonist of the type 1a growth hormone secretagogue receptor (GHS-R).
    Gauna C; van de Zande B; van Kerkwijk A; Themmen AP; van der Lely AJ; Delhanty PJ
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):30-4. PubMed ID: 17601657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
    Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
    J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
    Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
    J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.
    Liu B; Liu M; Xin Z; Zhao H; Serby MD; Kosogof C; Nelson LT; Szczepankiewicz BG; Kaszubska W; Schaefer VG; Falls HD; Lin CW; Collins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1864-8. PubMed ID: 16442284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
    Conti P; De Amici M; Grazioso G; Roda G; Pinto A; Hansen KB; Nielsen B; Madsen U; Bräuner-Osborne H; Egebjerg J; Vestri V; Pellegrini-Giampietro DE; Sibille P; Acher FC; De Micheli C
    J Med Chem; 2005 Oct; 48(20):6315-25. PubMed ID: 16190758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.
    Demange L; Boeglin D; Moulin A; Mousseaux D; Ryan J; Bergé G; Gagne D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
    J Med Chem; 2007 Apr; 50(8):1939-57. PubMed ID: 17375904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypes.
    Dallanoce C; Frigerio F; De Amici M; Dorsch S; Klotz KN; De Micheli C
    Bioorg Med Chem; 2007 Apr; 15(7):2533-43. PubMed ID: 17303428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
    Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
    J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.
    Zhao H; Xin Z; Liu G; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    J Med Chem; 2004 Dec; 47(27):6655-7. PubMed ID: 15615511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor.
    Van Craenenbroeck M; Gregoire F; De Neef P; Robberecht P; Perret J
    Peptides; 2004 Jun; 25(6):959-65. PubMed ID: 15203242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.
    Rudolph J; Esler WP; O'connor S; Coish PD; Wickens PL; Brands M; Bierer DE; Bloomquist BT; Bondar G; Chen L; Chuang CY; Claus TH; Fathi Z; Fu W; Khire UR; Kristie JA; Liu XG; Lowe DB; McClure AC; Michels M; Ortiz AA; Ramsden PD; Schoenleber RW; Shelekhin TE; Vakalopoulos A; Tang W; Wang L; Yi L; Gardell SJ; Livingston JN; Sweet LJ; Bullock WH
    J Med Chem; 2007 Oct; 50(21):5202-16. PubMed ID: 17887659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.